Visual electrophysiology company LKC Technologies reported on Friday the launch of its partnership with US Retina, one of the largest associations of private retina practices in the US with 203 member practices representing over 1,000 physicians, Group Purchasing Organisation (GPO).
US Retina reportedly provides valuable and immediate access to LKC's new technologies to advance the former's quality patient care, according to Peter L. Sonkin, MD, US Retina Board Member and Retinal Specialist at Tennessee Retina.
Helping the way physicians detect, diagnose and treat vision threatening diseases is the goal of every US Retina's retinal physician and LKC Technologies is the perfect partner to help US Retina's members gain access to high quality electrodiagnostic devices wherever they practice, added Dr L. Sonkin.
LKC is developing systems to provide objective functional information assisting in effective diagnosis of many ophthalmic conditions and vision threatening diseases. US Retina's vision is to lead the Retinal Vitreous industry toward high-quality and cost-effective healthcare, creating outcomes that exceed the expectations of its members, partners and patients.
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Elute partners Spartan Medical
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD
Abbott's Navitor TAVI system granted CE Mark for expanded indication
PharmaResearch names VIVACY as European distribution partner for Rejuran
Airiver medical receives FDA approval for central airway stenosis trial